01.10.1999
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated
with raloxifene. Results from a 3-year randomized clinical trial
B. Ettinger, D.M. Black, B.H. Mitlak, R.K. Knickerbocker, T. Nickelsen, H.K. Genant, C. Christiansen, P.D. Delmas, J.R. Zanchetta, J. Stakkestad, C.C. Glüer, K. Krueger, F.J. Cohen, S. Eckert, K.E. Ensrud, L.V. Avioli, P. Lips, S.R. Cummings, for the Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
JAMA, 1999; 282: 637-645